[O-023] Efficacy of interferon-β for myelin oligodendrocyte glycoprotein antibody-positive disorder.
○Kimihiko Kaneko1, Douglas Sato1,2, Ryo Ogawa1, Tetsuya Akaishi1, Yoshiki Takai1, Syuhei Nishiyama1, Toshiyuki Takahashi1,3, Tatsuro Misu1, Hiroshi Kuroda1, Ichiro Nakashima1,4,5, Kazuo Fujihara1,4,5, Masashi Aoki1 (1.Department of neurology, Tohoku University, Sendai, Japan, 2.Brain Institute and Hospital Sao Lucas Pontifical Catholic University of Rio Grande do Sul, Port Alegre, Brazil, 3.Department of neurology, NHO Yonezawa hospital, Yonezawa, Japan, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan, 5.Multiple Sclerosis and Neuromyelitis Optica Center, TOHOKU Research Institute for Neuroscience, Koriyama, Japan)